Keywords: ایمنی زایی; Influenza A virus; Gamma-irradiation; Immunogenicity; Protective immunity;
مقالات ISI ایمنی زایی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمنی زایی; Anti-drug antibodies (ADA); Immunogenicity; IL-5; Mepolizumab;
Keywords: ایمنی زایی; Human papillomavirus; Genital watts; Bivalent vaccine; Escherichia coli; Virus-like particle; Antigenicity; Immunogenicity;
Keywords: ایمنی زایی; Influenza vaccine; Antibody; Immunogenicity; Healthcare worker; Hemagglutination inhibition assay; Focus reduction assay; HCW; healthcare workers; HI; haemagglutination inhibition; MN; microneutralisation; GMT; geometric mean titre; GMR; geometric mean ra
Keywords: ایمنی زایی; Biopharmaceuticals; Biotherapeutics; Non-clinical safety; Hypersensitivity; Immunogenicity; Immune complex; Monoclonal antibodies; Risk mitigation; Non-human primate;
Keywords: ایمنی زایی; Nanostructured lipid carriers; Protein antigens; Ovalbumin; Adjuvant delivery systems; Immunogenicity; Vaccines;
Keywords: ایمنی زایی; protein formulation; accelerated stability; protein aggregation; subvisible particles; immunogenicity; microflow imaging; image analysis; quality control; regulatory science;
Keywords: ایمنی زایی; CD; Immunogenicity; Monitoring Therapy; Ulcerative Colitis; ATI; antibodies to infliximab; CD; Crohn's disease; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; HMSA; homogeneous mobility shift assay; HR; hazard ratio; IBD; inflammator
Keywords: ایمنی زایی; Influenza; Hemagglutinin inhibition; Seroconversion; Antibody; Influenza vaccine; Immunogenicity; Vaccine failure;
Keywords: ایمنی زایی; TB vaccine; Clinical trial; Safety; Immunogenicity;
Keywords: ایمنی زایی; NCT01295320; Varicella-zoster virus; Glycoprotein E; Subunit vaccine; Immunogenicity; Persistence;
Keywords: ایمنی زایی; tOPV; trivalent oral polio vaccine; PV3; poliovirus serotype 3; WHO; World Health Organization; MLR; multilevel logistic regression; SD; standard deviation; CI; confidence interval; OR; odds ratio; OPV; oral poliovirus vaccine; mOPV3; serotype-3 monovalen
Keywords: ایمنی زایی; MSD; MesoScale Discovery; ECL; electrochemiluminescence; ACE; affinity capture elution; ADA; anti-drug antibody; TAb; therapeutic antibody; MRD; minimum require dilution; TMB; 3,3â²,5,5â² tetramethylbenzidine; HRP; horseradish peroxidase; NHS; normal hu
Keywords: ایمنی زایی; FMDV; Capsid precursor polypeptide; Recombinant SeV-P1; Immunogenicity;
Keywords: ایمنی زایی; DTaP; Polio; Hib; Hepatitis B; Hexavalent; Vaccine; Safety; Immunogenicity; AE; adverse event(s); CI; confidence interval; D; diphtheria toxoid; DTaP5; diphtheria, tetanus, acellular pertussis (5-component) vaccine (Daptacelâ¢); DTPa3-HB-IPV/Hib; diphthe
Keywords: ایمنی زایی; PEDV S protein; Inclusion bodies; Solubilization; Refolding; Immunogenicity; Subunit vaccinePEDV, porcine epidemic diarrhea virus; IBs, inclusion bodies; IPTG, isopropyl d-1-thiogalactopyranoside; OD, optical density; DTT, dithiothreitol; TBS, Tris-buffer
Keywords: ایمنی زایی; Anti-drug antibody; Confirmatory; Cut point; Immunoassay; Immunogenicity; Screening; Specificity;
Keywords: ایمنی زایی; Calcium-alginate nanoparticles; Vaccination; Androctonus australis hector venom; Delivery system; Immunogenicity;
Keywords: ایمنی زایی; RetroVLPs; Virus-like particles; Retrovirus; CD81; CD9; CD63; Tetraspanins; Vaccines; Immunogenicity; Viral vectors;
Keywords: ایمنی زایی; Vaccinia virus; Immunogenicity; NF-κB inhibitor; IRF3 inhibitor; Vaccine efficacy;
Keywords: ایمنی زایی; Nanoparticles; Preclinical; Immunogenicity; Cytokines; Anaphylaxis; Phagocytosis; Antibody; Antigenicity
Keywords: ایمنی زایی; Biologic; Biosimilar; Biosimilarity; Characterization; Chronic inflammatory diseases; Clinical; Comparability; Development; Functional; Immunogenicity; Innovator; Manufacturing; Pharmacodynamics; Pharmacokinetics; Preclinical; Quality; Reference product;
Keywords: ایمنی زایی; Horse; Mesenchymal stem cells; Synovial fluid; Proinflammatory cytokines; Immunomodulation; Immunogenicity;
Keywords: ایمنی زایی; recombinant human erythropoietin; biosimilar; immunogenicity; physicochemical properties; protein characterization;
Keywords: ایمنی زایی; protein aggregation; immunogenicity; in vivo models;
Keywords: ایمنی زایی; Cerium dioxide; Influenza vaccine; Immunogenicity; Nanomaterials
Keywords: ایمنی زایی; APC; antigen-presenting cells; BcR; B cell receptor; EMA; European Medicines Agency; Fc; crystallizable fragment; FcγR; receptor for IgG Fc portion; FcRn; neonatal Fc receptor; FVIIa; activated factor VII; FVIII; factor VIII; GLP-1; glucagon-like peptide
Keywords: ایمنی زایی; Immunocompromised; Vaccines; Children; Immunogenicity; Safety; Recommendations;
Keywords: ایمنی زایی; Influenza vaccine; Quadrivalent; Immunogenicity; QIV; Intramuscular;
Keywords: ایمنی زایی; Newcastle disease virus; F gene; HN gene; Baculovirus expression vector system; Immunogenicity
Keywords: ایمنی زایی; Cut point; Pre-existing antibodies; Biopharmaceuticals; Anti-drug antibodies; Immunogenicity; Immunotoxin;
Keywords: ایمنی زایی; Biotherapeutics; PEGylated biologics; Gene and cell therapy; Pharmacokinetics; Nonclinical safety; Antibody-drug conjugate; Immunogenicity; Cross-reactive species;
Keywords: ایمنی زایی; Scaffolds; Decellularization; Biocompatibility; Immunogenicity; Biodegradability; Cytotoxicity;
Keywords: ایمنی زایی; Rabies virus; Preservation by vaporization; Stability; Efficacy; Immunogenicity; ECL; electrochemiluminescent; ERA; Evelyn-Rokitnicki-Abelseth; ffu; focus forming units; GMT; geometric mean titer; G; glycoprotein; IM; intramuscular; IU; international
Keywords: ایمنی زایی; antidrug antibody; elosulfase alfa; enzyme replacement therapy; immunogenicity; Morquio A syndrome; mucopolysaccharidosis;
Keywords: ایمنی زایی; Vaccine; Nanoparticles; Epitope; Immunogenicity; Computer-aided design; Bioinformatics;
Keywords: ایمنی زایی; TBE; tick-borne encephalitis; NT; neutralization test; ELISA; Enzyme Linked Immunosorbent Assay; ICH-GCP; International Conference on Harmonization-Good Clinical Practice; GMT; geometric mean titer; GMCs; geometric mean concentrations; PPS; per protocol d
Keywords: ایمنی زایی; Protamine; Heparin neutralization; Protamine toxicity; Immunogenicity; Cross-reactivity;
Keywords: ایمنی زایی; Fluoropeptide; Immunogenicity; Vaccine; Delivery system;
Keywords: ایمنی زایی; biosimilar; biologic; guidelines; clinical practice; inflammatory disorders; innovator; reference product; interchangeability; comparability; immunogenicity; extrapolation; pharmacokinetics; pharmacodynamics; pharmacovigilance; regulations; naming; labeli
Keywords: ایمنی زایی; Typhoid; Vaccine; Japan; Safety; Immunogenicity;
Keywords: ایمنی زایی; Pneumococcal polysaccharide vaccine; Immunogenicity; Opsonin; Phagocytosis; Elderly;
Keywords: ایمنی زایی; Influenza; Vaccine; Peptides; T cells; Immunogenicity; Safety; Fluoropeptides;
Keywords: ایمنی زایی; Pneumococcal conjugate vaccine; Vaccine clinical evaluation; Immunization; Immunogenicity; AE; adverse event; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; Ig; immunoglobulin; IPD; invasive pneumococ
Keywords: ایمنی زایی; Pneumococcal conjugate vaccine; Safety; Immunogenicity;
Keywords: ایمنی زایی; Low-dose diphtheria vaccine; Pre-school booster; Immunogenicity;
Keywords: ایمنی زایی; Amino acid composition; Collagen; Immunogenicity; Parasitic nematodes
Keywords: ایمنی زایی; ALV-J; Multi-epitope vaccine; Immunogenicity; Neutralizing antibodies; T-lymphocytes
Keywords: ایمنی زایی; Human butyrylcholinesterase; Pharmacokinetics; Immunogenicity; Aerosol delivery; Monkey model; Animal Rule; BChE; butyrylcholinesterase; Ma; macaque; aer; aerosol;
Keywords: ایمنی زایی; Immunogenicity; Anti-drug antibody; ADA; Drug interference; Drug tolerance; Target interference; Immunoassay; Ligand binding assays;